Safety and Efficacy Assessment Treatment Trials of Emixustat Hydrochloride
Status:
Completed
Trial end date:
2016-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if emixustat hydrochloride (ACU-4429) reduces the
rate of progression of geographic atrophy compared to placebo in subjects with dry
age-related macular degeneration.